Save information for later
Sign Up

Learn About Alveolar Soft Part Sarcoma

What is the definition of Alveolar Soft Part Sarcoma?
Alveolar soft part sarcoma (ASPS) is a rare, slow-growing soft tissue sarcoma. Although it has been described in a variety of locations, it most commonly develops on the lower extremities in adults and in the head and neck region of children. ASPS generally presents as a soft, pain-less lump that is often not associated with any additional signs and symptoms. In many cases, the condition is not diagnosed until the affected person develops symptoms of metastasis to other sites such as the lungs, bones, central nervous system and/or liver. The underlying cause of ASPS is poorly understood. Most cases occur sporadically in people with no family history of the condition.
What are the alternative names for Alveolar Soft Part Sarcoma?
  • Alveolar soft part sarcoma
  • ASPS
Who are the top Alveolar Soft Part Sarcoma Local Doctors?
Advanced in Alveolar Soft Part Sarcoma
Surgical Oncology
Advanced in Alveolar Soft Part Sarcoma
Surgical Oncology

University Health System, Inc.

1926 Alcoa Hwy, Suite 300, 
Knoxville, TN 
 (18.0 mi)
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

James Lewis is a Surgical Oncologist in Knoxville, Tennessee. Dr. Lewis and is rated as an Advanced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Rhabdomyosarcoma Embryonal, Epithelioid Sarcoma, and Mesenchymoma. Dr. Lewis is currently accepting new patients.

Experienced in Alveolar Soft Part Sarcoma
Oncology | Hematology
Experienced in Alveolar Soft Part Sarcoma
Oncology | Hematology

University Health System, Inc.

1924 Alcoa Hwy, 
Knoxville, TN 
 (17.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Timothy Panella is an Oncologist and a Hematologist in Knoxville, Tennessee. Dr. Panella and is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Melanoma, Breast Cancer, Paget Disease of the Breast, and Polymorphous Low Grade Adenocarcinoma. Dr. Panella is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Alveolar Soft Part Sarcoma
Gynecologic Oncology | Oncology
Experienced in Alveolar Soft Part Sarcoma
Gynecologic Oncology | Oncology

University Health System, Inc.

1924 Alcoa Hwy, U56, 
Knoxville, TN 
 (17.8 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Larry Kilgore is a Gynecologic Oncologist and an Oncologist in Knoxville, Tennessee. Dr. Kilgore and is rated as an Experienced provider by MediFind in the treatment of Alveolar Soft Part Sarcoma. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Desmoplastic Small Round Cell Tumor, and Malignant Mixed Mullerian Tumor. Dr. Kilgore is currently accepting new patients.

What are the latest Alveolar Soft Part Sarcoma Clinical Trials?
A Feasibility Multicenter Phase I Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to treat certain cancers. Researchers want to find out if lower doses of this drug might provide the same benefit with fewer adverse effec...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized Phase 2 Study of Atezolizumab With or Without Selinexor in Alveolar Soft Part Sarcoma (AXIOM)

Summary: This phase II trial tests whether atezolizumab alone or in combination with selinexor works to shrink tumors in patients with alveolar soft part sarcoma and whether the study drugs are better than the usual approach in treating this type of cancer. The usual approach is defined as care most people get for alveolar soft part sarcoma if they are not part of a clinical study, which includes treatment...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center